Number needed to treat in cardiac rehabilitation

Journal of Cardiopulmonary Rehabilitation

Volumn 22, Issue 1, 2002, Pages 22-30

  Oldridge, Neil ^a   Perkins, Anthony ^a   Marchionni, Niccolò ^a   Fumagalli, Stefano ^a   Fattirolli, Francesco ^a   Guyatt, Gordon ^a  

^a REGENSTRIEF INSTITUTE   (United States)

Author keywords

Cardiac rehabilitation; Exercise tolerance; Health related quality of life; Mortality; Number needed to treat

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EXERCISE; EXERCISE TEST; FEMALE; HEART INFARCTION; HEART REHABILITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0036053244     PISSN: 08839212     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008483-200201000-00003     Document Type: Article

References (42)

1. The number needed to treat: A clinically useful measure of treatment effect
2. An assessment of clinically useful measures of the consequences of treatment
3. Interpreting treatment effects in randomised trials
4. Using numerical results from systematic reviews in clinical practice
5. Cardiac rehabilitation after myocardial infarction: Combining data from randomized clinical trials
6. An overview of randomized trials of rehabilitation with exercise after myocardial infarction
7. Exercise-based rehabilitation for coronary heart disease. Cochrane review
8. Cardiac rehabilitation, self-responsibility, and quality of life
9. Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction
10. Aims, design and enrollment rate of the Cardiac Rehabilitation in Advanced Age (CR-AGE) randomized, controlled trial
11. Quality of life after myocardial infarction
12. A self-administered quality of life questionnaire after acute myocardial infarction
13. An improved questionnaire for assessing quality of life after myocardial infarction
14. Predictors of health-related quality of life with cardiac rehabilitation after acute myocardial infarction
15. The sickness impact profile: Development and final revision of a health status measure
16. The sickness impact profile
17. Differences in quality of life among male and female cardiac rehabilitation participants
18. Determinants of exercise tolerance after acute myocardial infarction in older persons
19. Assessing the minimal important difference in symptoms: A comparison of two techniques
20. The MacNew health-related quality of life instrument: Reference data for users
21. The cost and efficacy of home care for patients with chronic lung disease
22. The significance of treatment effects: The clinical perspective
23. Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II
24. Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation
25. The effect size statistic: Useful in health outcomes research?
26. Identifying meaningful intra-individual change standards for health-related quality of life measures
27. Comparisons of five health status instruments for orthopedic evaluation
28. Psychosocial outcome assessments for use in cardiac rehabilitation service evaluation: A 10-year systematic review
29. Number needed to treat: Solid science or a path to pernicious rationing?
30. ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
31. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Study (4S)
32. Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies
33. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
34. Beta blockade after myocardial infarction: Systematic review and meta regression analysis
35. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
36. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
37. The effect of diltiazem on mortality and reinfarction after myocardial infarction
38. Economic analysis of respiratory rehabilitation
39. Follow-up after six months of cardiac rehabilitation in elderly patients with myocardial infarction. Preliminary results of the CR-AGE randomized controlled trial